Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ANDA Submissions To US FDA Expected To Decline; Generic User Fees For FY 2019 Will Rise
29 Jul 2018
•
By
Derrick Gingery
FDA's predictions have been pretty consistent; actual submissions haven't been.
More from Generics
More from Biosimilars & Generics